\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ physical\\ exam\\,\\ a\\ hard\\ mass\\ was\\ palpable\\ on\\ the\\ medial\\ aspect\\ of\\ the\\ left\\ amputation\\ site\\.\ \(0\)\
\-\ patient\\ was\\ taken\\ to\\ the\\ operating\\ room\\ for\\ resection\\ of\\ the\\ heterotopic\\ ossification\\.\\ \\ after\\ resection\\,\\ patient\\'s\\ complaint\\ of\\ pain\\ with\\ prosthesis\\ use\\ was\\ relieved\\.\ \(0\)\
\-\ preoperative\\ anteroposterior\\ and\\ lateral\\ radiographs\\ of\\ left\\ knee\\ shows\\ through\\-knee\\-amputation\\ with\\ irregularly\\ bordered\\ heterogeneous\\ ossified\\ densities\\ juxtaposed\\ to\\ the\\ posteromedial\\ aspect\\ of\\ the\\ distal\\ femur\\.\\ \\ these\\ ossifications\\ extend\\ through\\ the\\ soft\\ tissues\\ and\\ are\\ consistent\\ with\\ heterotopic\\ ossification\\.\\ \\ the\\ left\\ femur\\ shows\\ normal\\ bone\\ density\\.\\ \\ the\\ remainder\\ of\\ the\\ soft\\ tissues\\ appear\\ normal\\.\ \(0\)\
\-\ postoperative\\ anterioposterior\\ and\\ lateral\\ radiographs\\ of\\ left\\ knee\\ shows\\ through\\-knee\\-amputation\\ with\\ small\\ residual\\ focal\\ ossified\\ densities\\ near\\ the\\ medial\\ epicondyle\\ and\\ the\\ medial\\ condyle\\.\\ \\ the\\ posterior\\ aspect\\ of\\ the\\ distal\\ femur\\ also\\ shows\\ focal\\ area\\ of\\ ossified\\ densities\\.\\ \\ a\\ percutaneous\\ drain\\ is\\ in\\ place\\ in\\ the\\ soft\\ tissue\\ distal\\ to\\ the\\ medial\\ condyle\\.\\ \\ postoperative\\ air\\ is\\ seen\\ in\\ the\\ soft\\ tissues\\.\ \(0\)\
\-\ heterotopic\\ ossification\ \(17\)\
\-\ the\\ history\\ of\\ trauma\\ combined\\ with\\ the\\ clinical\\ course\\ and\\ radiographic\\ findings\\ of\\ the\\ ossifications\\ in\\ the\\ soft\\ tissue\\ are\\ characteristic\\ of\\ heterotopic\\ officiation\\.\ \(0\)\
\-\ 29\\ year\\ old\\ active\\ duty\\ usmc\\ male\\ who\\ sustained\\ an\\ improvised\\ explosive\\ device\\ \\(ied\\)\\ blast\\ to\\ bilateral\\ lower\\ extremities\\ and\\ who\\ eventually\\ required\\ a\\ through\\-knee\\-amputation\\ in\\ march\\ 2005\\.\\ \\ in\\ january\\ 2006\\ patient\\ was\\ seen\\ in\\ the\\ orthopedic\\ clinic\\ with\\ complaints\\ of\\ pain\\ in\\ left\\ amputation\\ site\\ with\\ prosthesis\\ use\\.\\ \\ patient\\ denied\\ fevers\\,\\ chills\\,\\ night\\ sweats\\,\\ or\\ weight\\ loss\\.\ \(0\)\
\-\ heterotopic\\ ossification\\ \\(ho\\)\\ is\\ the\\ formation\\ of\\ bone\\ in\\ abnormal\\ locations\\.\\(1\\-7\\)\\ \\ ho\\ is\\ a\\ well\\-acknowledged\\ entity\\ that\\ is\\ commonly\\ divided\\ into\\ three\\ categories\\:\\ genetic\\,\\ traumatic\\,\\ and\\ neurogenic\\.\\ \\ ho\\ has\\ recently\\ become\\ a\\ significant\\ problem\\ for\\ the\\ many\\ amputees\\ from\\ operation\\ enduring\\ freedom\\ \\(oef\\)\\ and\\ operation\\ iraqi\\ freedom\\ \\(oif\\)\\.\\(1\\)\ \(0\)\
\-\ ho\\ occurs\\ frequently\\ in\\ many\\ traumatic\\ events\\ including\\ spinal\\ cord\\ injuries\\ \\(20\\%\\ \\-\\ 30\\%\\)\\,\\ closed\\ head\\ injuries\\ \\(10\\%\\ \\-\\ 20\\%\\)\\,\\ fractures\\,\\ dislocations\\,\\ and\\ burns\\.\\ \\ ho\\ also\\ frequently\\ occurs\\ after\\ various\\ medical\\ interventions\\ such\\ as\\ amputation\\ \\(62\\%\\)\\,\\ total\\ hip\\ arthroscopy\\ \\(43\\%\\)\\ and\\ open\\ reduction\\ internal\\ fixation\\.\\(1\\-3\\)\\ \\ more\\ rare\\ causes\\ of\\ ho\\ that\\ have\\ been\\ reported\\ include\\ encephalitis\\,\\ meningitis\\,\\ tetanus\\,\\ brain\\ tumors\\,\\ epidural\\ abscess\\,\\ and\\ subarachnoid\\ hemorrhage\\.\\(3\\)\ \(0\)\
\-\ ho\\ is\\ believed\\ to\\ originate\\ from\\ inappropriate\\ recruitment\\ or\\ differentiation\\ of\\ pluripotent\\ mesenchymal\\ cells\\ into\\ osteogenic\\ cells\\.\\ \\ two\\ factors\\ proposed\\ to\\ induce\\ this\\ recruitment\\ or\\ differentiation\\ are\\ bone\\ morphogenic\\ protein\\-4\\ \\(bmp\\-4\\)\\ and\\ prostaglandins\\ e2\\ \\(pge2\\)\\.\\(1\\,2\\,4\\)\\ various\\ risk\\ factors\\ have\\ been\\ identified\\ for\\ the\\ development\\ of\\ ho\\ including\\ male\\ gender\\,\\ history\\ of\\ ho\\,\\ hypertrophic\\ osteoarthritis\\,\\ ankylosing\\ spondylitis\\,\\ multiple\\ injuries\\,\\ and\\ lateral\\ approach\\ in\\ total\\ hip\\ arthroscopy\\.\\(3\\)\ \(0\)\
\-\ most\\ patients\\ with\\ ho\\ are\\ completely\\ asymptomatic\\.\\ \\ patients\\ who\\ are\\ symptomatic\\ commonly\\ complain\\ initially\\ of\\ nonspecific\\ signs\\ and\\ symptoms\\ including\\ fever\\,\\ erythema\\,\\ swelling\\,\\ and\\ pain\\.\\ \\ later\\,\\ they\\ begin\\ to\\ complain\\ of\\ decreased\\ joint\\ mobility\\ and\\ continued\\ pain\\ despite\\ improvement\\ of\\ their\\ fever\\,\\ erythema\\,\\ and\\ swelling\\.\\(2\\)\\ \\ many\\ traumatic\\ amputees\\ with\\ ho\\ complain\\ of\\ pain\\ with\\ prostheses\\ use\\.\\(1\\)\ \(0\)\
\-\ ho\\ is\\ most\\ commonly\\ diagnosed\\ incidentally\\ on\\ plain\\ radiographs\\.\\ \\ the\\ typical\\ radiographic\\ appearance\\ of\\ ho\\,\\ when\\ mature\\,\\ is\\ focal\\ distinctive\\ ossifications\\ in\\ the\\ muscle\\ and\\ other\\ soft\\ tissue\\.\\ \\ they\\ also\\ may\\ be\\ contiguous\\ with\\ the\\ periosteum\\ of\\ bone\\.\\ \\ four\\ to\\ six\\ weeks\\ after\\ the\\ inciting\\ event\\,\\ plain\\ radiographs\\ usually\\ show\\ mature\\ ho\\ lesions\\.\\ \\ although\\ plain\\ radiographs\\ are\\ adequate\\ to\\ diagnosis\\ ho\\,\\ three\\-phase\\ bone\\ scintigraphy\\ has\\ been\\ shown\\ to\\ be\\ able\\ to\\ detect\\ ho\\ earlier\\ \\(2\\.5\\ weeks\\ after\\ inciting\\ event\\)\\.\\(2\\,5\\)\\ \\ alkaline\\ phosphatase\\ and\\ 24\\-hour\\ pge2\\ urinary\\ excretion\\ are\\ also\\ used\\ as\\ an\\ adjunct\\ in\\ diagnosing\\ ho\\.\\(2\\)\ \(0\)\
\-\ common\\ complications\\ of\\ ho\\ needing\\ intervention\\ include\\ decreased\\ range\\-of\\-motion\\,\\ pain\\,\\ peripheral\\ nerve\\ entrapments\\,\\ and\\ pressure\\ ulcers\\.\\ \\ traumatic\\ amputees\\ with\\ ho\\ have\\ the\\ additional\\ complication\\ with\\ prosthesis\\ fitting\\.\\(1\\)\ \(0\)\
\-\ management\\ of\\ ho\\ is\\ controversial\\ with\\ new\\ therapies\\ on\\ the\\ horizon\\.\\ \\ the\\ most\\ common\\ management\\ strategies\\ for\\ ho\\ are\\ radiation\\ therapy\\ and\\ nsaids\\.\\ \\ numerous\\ studies\\ have\\ been\\ conducted\\ evaluating\\ the\\ efficacy\\ of\\ both\\ radiation\\ therapy\\ and\\ nsaids\\ as\\ well\\ as\\ comparing\\ the\\ efficacy\\ between\\ the\\ two\\ management\\ strategies\\.\\ \\ there\\ does\\ not\\ appear\\ to\\ be\\ a\\ difference\\ between\\ the\\ efficacy\\ of\\ radiation\\ therapy\\ and\\ nsaids\\ in\\ preventing\\ ho\\ development\\.\\ \\ seven\\ gy\\ of\\ radiation\\ therapy\\ is\\ commonly\\ given\\ within\\ 24\\ hours\\ pre\\-operation\\ of\\ total\\ hip\\ arthroplasty\\.\\ \\ there\\ is\\ no\\ consensus\\ of\\ which\\ nsaid\\ is\\ most\\ effective\\,\\ but\\ commonly\\ a\\ 5\\-6\\ week\\ period\\ of\\ nsaids\\ is\\ administered\\ post\\-operation\\.\\(6\\)\\ \\ resection\\ is\\ the\\ last\\ management\\ modality\\ that\\ is\\ used\\ with\\ symptomatic\\ ho\\.\\ \\ resection\\ is\\ usually\\ done\\ only\\ after\\ radiologic\\ and\\ laboratory\\ evidence\\ of\\ metabolic\\ inactivity\\ of\\ the\\ ho\\.\\(2\\)\\ \\ various\\ animal\\ studies\\ have\\ shown\\ promise\\ for\\ a\\ bmp\\-4\\ antagonist\\ \\(noggin\\)\\ for\\ those\\ who\\ are\\ at\\ risk\\ for\\ ho\\ development\\.\\(4\\)\ \(0\)\
\-\ references\ \(24\)\
\-\ 1\\.\\ potter\\ bk\\,\\ burns\\ tc\\,\\ lacap\\ ap\\,\\ granville\\ rr\\,\\ gajewski\\ d\\.\\ \\ heterotopic\\ ossification\\ in\\ the\\ residual\\ limbs\\ of\\ traumatic\\ and\\ combat\\-related\\ amputees\\.\\ \\ jaaos\\ 2006\\;\\ 14\\:s191\\-s197\\.\ \(0\)\
\-\ 2\\.\\ shehab\\ d\\,\\ elgazzar\\ ah\\,\\ collier\\ bd\\.\\ \\ heterotopic\\ ossification\\.\\ \\ j\\ nucl\\ med\\ 2002\\;\\ 43\\:346\\-353\\.\ \(0\)\
\-\ 3\\.\\ balboni\\ ta\\,\\ gobezie\\ r\\,\\ mamon\\ hj\\.\\ \\ heterotopic\\ ossification\\:\\ pathophysiology\\,\\ clinical\\ features\\,\\ and\\ the\\ role\\ of\\ radiotherapy\\ for\\ prophylaxis\\.\\ \\ int\\ j\\ radiation\\ oncology\\ biol\\ phys\\ 2006\\;\\ 65\\:\\ 1289\\-1299\\.\ \(0\)\
\-\ 4\\.\\ kaplan\\ fs\\,\\ glaser\\ dl\\,\\ hebela\\ n\\,\\ shore\\ em\\.\\ \\ heterotopic\\ ossification\\.\\ \\ jaaos\\ 2004\\;\\ 12\\:116\\-125\\.\ \(0\)\
\-\ 5\\.\\ henrot\\ p\\,\\ stines\\ j\\,\\ walter\\ f\\,\\ martinet\\ n\\,\\ paysant\\ j\\,\\ blum\\ a\\.\\ \\ imaging\\ of\\ the\\ painful\\ lower\\ limb\\ stump\\.\\ \\ radiographics\\ 2000\\;\\ 20\\:s219\\-235\\.\ \(0\)\
\-\ 6\\.\\ burd\\ ta\\,\\ lowry\\ kj\\,\\ anglen\\ jo\\.\\ \\ indomethacin\\ compared\\ with\\ localized\\ irradiation\\ for\\ the\\ prevention\\ of\\ heterotopic\\ ossification\\ following\\ surgical\\ treatment\\ of\\ acetabular\\ fractures\\.\\ \\ jbjs\\ \\(am\\)\\ 2001\\;\\ 83\\:1783\\-1788\\.\ \(0\)\
\-\ 7\\.\\ iorio\\ r\\,\\ healy\\ wl\\.\\ \\ heterotopic\\ ossification\\ after\\ hip\\ and\\ knee\\ arthroplasty\\:\\ risk\\ factors\\,\\ prevention\\,\\ and\\ treatment\\.\\ \\ jaaos\\ 2002\\;\\ 10\\:409\\-416\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ho\\:\\ 0\\.6323498357028615\ \(0\)\
\-\ heterotopic\\:\\ 0\\.23144765966597264\ \(0\)\
\-\ ossification\\:\\ 0\\.1850572195806627\ \(0\)\
\-\ the\\:\\ 0\\.16676876052126727\ \(0\)\
\-\ of\\:\\ 0\\.15577029135269\ \(0\)\
\-\ amputation\\:\\ 0\\.13725577405465772\ \(0\)\
\-\ amputees\\:\\ 0\\.12729496244624647\ \(0\)\
\-\ and\\:\\ 0\\.11513605595289363\ \(0\)\
\-\ jaaos\\:\\ 0\\.09122784930259717\ \(0\)\
\-\ operation\\:\\ 0\\.09046975222336769\ \(0\)\
\-\ is\\:\\ 0\\.08719410820668619\ \(0\)\
\-\ knee\\:\\ 0\\.08558261717017035\ \(0\)\
\-\ ossifications\\:\\ 0\\.08397375604558266\ \(0\)\
\-\ nsaids\\:\\ 0\\.07788467869263548\ \(0\)\
\-\ traumatic\\:\\ 0\\.07539664357698062\ \(0\)\
\-\ in\\:\\ 0\\.0742554986387478\ \(0\)\
\-\ commonly\\:\\ 0\\.07362362398871822\ \(0\)\
\-\ prosthesis\\:\\ 0\\.0730744784566879\ \(0\)\
\-\ efficacy\\:\\ 0\\.07247629025648045\ \(0\)\
\-\ ossified\\:\\ 0\\.06946556953155363\ \(0\)\
\-\ are\\:\\ 0\\.06795882761906216\ \(0\)\
\-\ complain\\:\\ 0\\.06613280972473755\ \(0\)\
\-\ radiation\\:\\ 0\\.06593553320877947\ \(0\)\
\-\ radiographs\\:\\ 0\\.06453297715252869\ \(0\)\
\-\ recruitment\\:\\ 0\\.06364748122312323\ \(0\)\
\-\ pge2\\:\\ 0\\.06364748122312323\ \(0\)\
\-\ soft\\:\\ 0\\.06356463772411854\ \(0\)\
\-\ with\\:\\ 0\\.06234534562586208\ \(0\)\
\-\ hip\\:\\ 0\\.06114533300280359\ \(0\)\
\-\ densities\\:\\ 0\\.05970319336216023\ \(0\)\
\-\ various\\:\\ 0\\.05970319336216023\ \(0\)\
\-\ to\\:\\ 0\\.05969823349260956\ \(0\)\
\-\ 2006\\:\\ 0\\.059533019785581245\ \(0\)\
\-\ freedom\\:\\ 0\\.05881141905178022\ \(0\)\
\-\ management\\:\\ 0\\.05879553630483723\ \(0\)\
\-\ after\\:\\ 0\\.05792163849352972\ \(0\)\
\-\ strategies\\:\\ 0\\.057254554770202935\ \(0\)\
\-\ bone\\:\\ 0\\.0542891213401067\ \(0\)\
\-\ for\\:\\ 0\\.054282655730158134\ \(0\)\
\-\ burns\\:\\ 0\\.05397535688043722\ \(0\)\
\-\ ta\\:\\ 0\\.053153589008996645\ \(0\)\
\-\ injuries\\:\\ 0\\.0520287446299848\ \(0\)\
\-\ medial\\:\\ 0\\.051812436822748206\ \(0\)\
\-\ resection\\:\\ 0\\.05102352659463965\ \(0\)\
\-\ inciting\\:\\ 0\\.05058798685622892\ \(0\)\
\-\ factors\\:\\ 0\\.050498220482308016\ \(0\)\
\-\ have\\:\\ 0\\.04970462749185492\ \(0\)\
\-\ development\\:\\ 0\\.04935294670686571\ \(0\)\
\-\ femur\\:\\ 0\\.04897690226327841\ \(0\)\
\-\ total\\:\\ 0\\.04891552118193743\ \(0\)\
\-\ prevention\\:\\ 0\\.048716318971125265\ \(0\)\
\-\ arthroscopy\\:\\ 0\\.04794030184009455\ \(0\)\
\-\ through\\:\\ 0\\.047382953770760884\ \(0\)\
\-\ arthroplasty\\:\\ 0\\.04724202326163506\ \(0\)\
\-\ tissues\\:\\ 0\\.04706882615355667\ \(0\)\
\-\ many\\:\\ 0\\.04706882615355667\ \(0\)\
\-\ shows\\:\\ 0\\.04671729851254027\ \(0\)\
\-\ been\\:\\ 0\\.04637485369908473\ \(0\)\
\-\ therapy\\:\\ 0\\.04573436866078138\ \(0\)\
\-\ use\\:\\ 0\\.04567777540785579\ \(0\)\
\-\ who\\:\\ 0\\.045025695461280775\ \(0\)\
\-\ pain\\:\\ 0\\.042724785531404075\ \(0\)\
\-\ including\\:\\ 0\\.04272335091533339\ \(0\)\
\-\ risk\\:\\ 0\\.04265583168521209\ \(0\)\
\-\ mature\\:\\ 0\\.04257408881392982\ \(0\)\
\-\ most\\:\\ 0\\.041425350097638966\ \(0\)\
\-\ postoperative\\:\\ 0\\.041330457514273486\ \(0\)\
\-\ event\\:\\ 0\\.03968867985705416\ \(0\)\
\-\ plain\\:\\ 0\\.03938751258389795\ \(0\)\
\-\ condyle\\:\\ 0\\.03864540249496762\ \(0\)\
\-\ differentiation\\:\\ 0\\.03864540249496762\ \(0\)\
\-\ aspect\\:\\ 0\\.03851390205757846\ \(0\)\
\-\ 20\\:\\ 0\\.03851390205757846\ \(0\)\
\-\ 2002\\:\\ 0\\.038086947492151114\ \(0\)\
\-\ also\\:\\ 0\\.0374407450128176\ \(0\)\
\-\ 43\\:\\ 0\\.037245330495197466\ \(0\)\
\-\ residual\\:\\ 0\\.03621527960704745\ \(0\)\
\-\ erythema\\:\\ 0\\.036013034637371745\ \(0\)\
\-\ focal\\:\\ 0\\.035709065566590384\ \(0\)\
\-\ distal\\:\\ 0\\.03468642972413992\ \(0\)\
\-\ left\\:\\ 0\\.033940882452110424\ \(0\)\
\-\ frequently\\:\\ 0\\.03277549038124948\ \(0\)\
\-\ site\\:\\ 0\\.03209913002502351\ \(0\)\
\-\ as\\:\\ 0\\.03197745006254833\ \(0\)\
\-\ officiation\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ enduring\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ oef\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ pluripotent\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ noggin\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ lacap\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ granville\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ gajewski\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ shehab\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ elgazzar\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ balboni\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ gobezie\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ mamon\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ glaser\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ hebela\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ henrot\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ stines\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ martinet\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ paysant\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ burd\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ lowry\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ anglen\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ iorio\\:\\ 0\\.03182374061156162\ \(0\)\
\-\ occurs\\:\\ 0\\.03137921743570444\ \(0\)\
\-\ appear\\:\\ 0\\.03134510018966651\ \(0\)\
\-\ tissue\\:\\ 0\\.031316593770960355\ \(0\)\
\-\ shown\\:\\ 0\\.03085240404227716\ \(0\)\
\-\ cells\\:\\ 0\\.030664671741197733\ \(0\)\
\-\ symptomatic\\:\\ 0\\.03060320030467373\ \(0\)\
\-\ anterioposterior\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ morphogenic\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ entrapments\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ horizon\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ inactivity\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ antagonist\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ collier\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ biol\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ shore\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ blum\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ healy\\:\\ 0\\.030409283100865724\ \(0\)\
\-\ used\\:\\ 0\\.029795046023722176\ \(0\)\
\-\ lateral\\:\\ 0\\.02962715501695425\ \(0\)\
\-\ radiographic\\:\\ 0\\.029527696728655153\ \(0\)\
\-\ fractures\\:\\ 0\\.02942356102065552\ \(0\)\
\-\ juxtaposed\\:\\ 0\\.02940570952589011\ \(0\)\
\-\ usmc\\:\\ 0\\.02940570952589011\ \(0\)\
\-\ prostaglandins\\:\\ 0\\.02940570952589011\ \(0\)\
\-\ ah\\:\\ 0\\.02940570952589011\ \(0\)\
\-\ jbjs\\:\\ 0\\.02940570952589011\ \(0\)\
\-\ wl\\:\\ 0\\.02940570952589011\ \(0\)\
\-\ studies\\:\\ 0\\.029194787642927565\ \(0\)\
\-\ iraqi\\:\\ 0\\.028627277385101468\ \(0\)\
\-\ e2\\:\\ 0\\.028627277385101468\ \(0\)\
\-\ potter\\:\\ 0\\.028627277385101468\ \(0\)\
\-\ bk\\:\\ 0\\.028627277385101468\ \(0\)\
\-\ kaplan\\:\\ 0\\.028627277385101468\ \(0\)\
\-\ they\\:\\ 0\\.028437221123474726\ \(0\)\
\-\ 24\\:\\ 0\\.028216412729439096\ \(0\)\
\-\ oif\\:\\ 0\\.02799125201519422\ \(0\)\
\-\ promise\\:\\ 0\\.02799125201519422\ \(0\)\
\-\ hj\\:\\ 0\\.02799125201519422\ \(0\)\
\-\ stump\\:\\ 0\\.02799125201519422\ \(0\)\
\-\ kj\\:\\ 0\\.02799125201519422\ \(0\)\
\-\ was\\:\\ 0\\.027740785181499472\ \(0\)\
\-\ tetanus\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ induce\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ needing\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ bd\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ nucl\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ walter\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ jo\\:\\ 0\\.027453500227184933\ \(0\)\
\-\ bordered\\:\\ 0\\.02698767844021861\ \(0\)\
\-\ prostheses\\:\\ 0\\.02698767844021861\ \(0\)\
\-\ fitting\\:\\ 0\\.02698767844021861\ \(0\)\
\-\ gy\\:\\ 0\\.02698767844021861\ \(0\)\
\-\ animal\\:\\ 0\\.02698767844021861\ \(0\)\
\-\ indomethacin\\:\\ 0\\.02698767844021861\ \(0\)\
\-\ fever\\:\\ 0\\.026984323875512344\ \(0\)\
\-\ swelling\\:\\ 0\\.026786764751034097\ \(0\)\
\-\ three\\:\\ 0\\.02671628977896543\ \(0\)\
\-\ inappropriate\\:\\ 0\\.026576794504498322\ \(0\)\
\-\ distinctive\\:\\ 0\\.026576794504498322\ \(0\)\
\-\ em\\:\\ 0\\.026209246299429962\ \(0\)\
\-\ that\\:\\ 0\\.025906998115630443\ \(0\)\
\-\ patient\\:\\ 0\\.025889321332320903\ \(0\)\
\-\ phys\\:\\ 0\\.02587675850461325\ \(0\)\
\-\ between\\:\\ 0\\.025859549589127003\ \(0\)\
\-\ improvised\\:\\ 0\\.025573220929522713\ \(0\)\
\-\ comparing\\:\\ 0\\.025573220929522713\ \(0\)\
\-\ int\\:\\ 0\\.025573220929522713\ \(0\)\
\-\ epicondyle\\:\\ 0\\.02529399342811446\ \(0\)\
\-\ nsaid\\:\\ 0\\.02529399342811446\ \(0\)\
\-\ clinical\\:\\ 0\\.025222820851485545\ \(0\)\
\-\ usually\\:\\ 0\\.02505503008966533\ \(0\)\
\-\ explosive\\:\\ 0\\.025035469141513427\ \(0\)\
\-\ originate\\:\\ 0\\.025035469141513427\ \(0\)\
\-\ adjunct\\:\\ 0\\.025035469141513427\ \(0\)\
\-\ consensus\\:\\ 0\\.025035469141513427\ \(0\)\
\-\ osteogenic\\:\\ 0\\.024794788788734066\ \(0\)\
\-\ decreased\\:\\ 0\\.02465240129791059\ \(0\)\
\-\ fs\\:\\ 0\\.024569647354547103\ \(0\)\
\-\ irradiation\\:\\ 0\\.024569647354547103\ \(0\)\
\-\ ied\\:\\ 0\\.024358159485562633\ \(0\)\
\-\ be\\:\\ 0\\.024217377003341787\ \(0\)\
\-\ on\\:\\ 0\\.024040043845538282\ \(0\)\
\-\ weeks\\:\\ 0\\.023852402439175788\ \(0\)\
\-\ blast\\:\\ 0\\.023791215213758456\ \(0\)\
\-\ include\\:\\ 0\\.023680122996931705\ \(0\)\
\-\ two\\:\\ 0\\.023634891312338865\ \(0\)\
\-\ posteromedial\\:\\ 0\\.02362101163081753\ \(0\)\
\-\ january\\:\\ 0\\.02362101163081753\ \(0\)\
\-\ categories\\:\\ 0\\.02362101163081753\ \(0\)\
\-\ preventing\\:\\ 0\\.02362101163081753\ \(0\)\
\-\ events\\:\\ 0\\.023458727418941745\ \(0\)\
\-\ periosteum\\:\\ 0\\.023458727418941745\ \(0\)\
\-\ mesenchymal\\:\\ 0\\.02330365826952627\ \(0\)\
\-\ gender\\:\\ 0\\.02330365826952627\ \(0\)\
\-\ therapies\\:\\ 0\\.02330365826952627\ \(0\)\
\-\ limbs\\:\\ 0\\.02330365826952627\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.02330365826952627\ \(0\)\
\-\ 10\\:\\ 0\\.023272512817619977\ \(0\)\
\-\ anteroposterior\\:\\ 0\\.023155189843851207\ \(0\)\
\-\ interventions\\:\\ 0\\.023155189843851207\ \(0\)\
\-\ difference\\:\\ 0\\.023155189843851207\ \(0\)\
\-\ proposed\\:\\ 0\\.02301278307296981\ \(0\)\
\-\ begin\\:\\ 0\\.02301278307296981\ \(0\)\
\-\ conducted\\:\\ 0\\.02301278307296981\ \(0\)\
\-\ phosphatase\\:\\ 0\\.022875962342442956\ \(0\)\
\-\ controversial\\:\\ 0\\.022744305908130924\ \(0\)\
\-\ acetabular\\:\\ 0\\.022744305908130924\ \(0\)\
\-\ march\\:\\ 0\\.02261743805584192\ \(0\)\
\-\ excretion\\:\\ 0\\.02261743805584192\ \(0\)\
\-\ common\\:\\ 0\\.022570668196194014\ \(0\)\
\-\ irregularly\\:\\ 0\\.02249502263741326\ \(0\)\
\-\ patients\\:\\ 0\\.022389190072623227\ \(0\)\
\-\ alkaline\\:\\ 0\\.02237675770306256\ \(0\)\
\-\ diagnosing\\:\\ 0\\.02237675770306256\ \(0\)\
\-\ mobility\\:\\ 0\\.022262371014198586\ \(0\)\
\-\ operating\\:\\ 0\\.022151616268875598\ \(0\)\
\-\ divided\\:\\ 0\\.022151616268875598\ \(0\)\
\-\ dislocations\\:\\ 0\\.021940128399891127\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.021940128399891127\ \(0\)\
\-\ preoperative\\:\\ 0\\.021645151519786278\ \(0\)\
\-\ entity\\:\\ 0\\.021645151519786278\ \(0\)\
\-\ neurogenic\\:\\ 0\\.021645151519786278\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.021552119834375768\ \(0\)\
\-\ ankylosing\\:\\ 0\\.02146150483174706\ \(0\)\
\-\ detect\\:\\ 0\\.02146150483174706\ \(0\)\
\-\ seven\\:\\ 0\\.02146150483174706\ \(0\)\
\-\ device\\:\\ 0\\.02137318412808695\ \(0\)\
\-\ believed\\:\\ 0\\.02128704440696491\ \(0\)\
\-\ oncology\\:\\ 0\\.02128704440696491\ \(0\)\
\-\ spondylitis\\:\\ 0\\.021202980545146025\ \(0\)\
\-\ into\\:\\ 0\\.021156535049632462\ \(0\)\
\-\ ulcers\\:\\ 0\\.020962300192366664\ \(0\)\
\-\ relieved\\:\\ 0\\.020885627183854765\ \(0\)\
\-\ role\\:\\ 0\\.020885627183854765\ \(0\)\
\-\ locations\\:\\ 0\\.02081060318575221\ \(0\)\
\-\ or\\:\\ 0\\.020768115601880764\ \(0\)\
\-\ hypertrophic\\:\\ 0\\.0207371587581797\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.020665228757136743\ \(0\)\
\-\ administered\\:\\ 0\\.020594751987298304\ \(0\)\
\-\ contiguous\\:\\ 0\\.02052567088919523\ \(0\)\
\-\ lower\\:\\ 0\\.020337401485533747\ \(0\)\
\-\ sustained\\:\\ 0\\.02032627482245942\ \(0\)\
\-\ sweats\\:\\ 0\\.02032627482245942\ \(0\)\
\-\ effective\\:\\ 0\\.02032627482245942\ \(0\)\
\-\ radiographics\\:\\ 0\\.02007699155174176\ \(0\)\
\-\ evaluating\\:\\ 0\\.02001735793796678\ \(0\)\
\-\ med\\:\\ 0\\.02001735793796678\ \(0\)\
\-\ limb\\:\\ 0\\.01990106445405341\ \(0\)\
\-\ 2000\\:\\ 0\\.01990106445405341\ \(0\)\
\-\ drain\\:\\ 0\\.01984433992852708\ \(0\)\
\-\ eventually\\:\\ 0\\.01984433992852708\ \(0\)\
\-\ encephalitis\\:\\ 0\\.01978852303445013\ \(0\)\
\-\ combined\\:\\ 0\\.019733585183204096\ \(0\)\
\-\ hard\\:\\ 0\\.019679499115982803\ \(0\)\
\-\ modality\\:\\ 0\\.019679499115982803\ \(0\)\
\-\ genetic\\:\\ 0\\.019626238822574343\ \(0\)\
\-\ problem\\:\\ 0\\.019626238822574343\ \(0\)\
\-\ adequate\\:\\ 0\\.01937149199325201\ \(0\)\
\-\ closed\\:\\ 0\\.01932270124748381\ \(0\)\
\-\ well\\:\\ 0\\.019270937379031048\ \(0\)\
\-\ tc\\:\\ 0\\.019227120434114776\ \(0\)\
\-\ percutaneous\\:\\ 0\\.019180294476602407\ \(0\)\
\-\ approach\\:\\ 0\\.019088487034565057\ \(0\)\
\-\ treatment\\:\\ 0\\.018958439828380424\ \(0\)\
\-\ 62\\:\\ 0\\.018955153042415445\ \(0\)\
\-\ duty\\:\\ 0\\.01886901332129341\ \(0\)\
\-\ am\\:\\ 0\\.01878494945947452\ \(0\)\
\-\ 2001\\:\\ 0\\.01878494945947452\ \(0\)\
\-\ meningitis\\:\\ 0\\.018743665173430974\ \(0\)\
\-\ 2004\\:\\ 0\\.018743665173430974\ \(0\)\
\-\ seen\\:\\ 0\\.018737110530219182\ \(0\)\
\-\ nonspecific\\:\\ 0\\.018702863755608284\ \(0\)\
\-\ fixation\\:\\ 0\\.018583246958634184\ \(0\)\
\-\ radiologic\\:\\ 0\\.018544269106695162\ \(0\)\
\-\ extend\\:\\ 0\\.018355656607915615\ \(0\)\
\-\ rr\\:\\ 0\\.018282977282102077\ \(0\)\
\-\ has\\:\\ 0\\.01817908523595527\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.018176720901626798\ \(0\)\
\-\ earlier\\:\\ 0\\.018176720901626798\ \(0\)\
\-\ chills\\:\\ 0\\.018107639803523725\ \(0\)\
\-\ epidural\\:\\ 0\\.018073605568145197\ \(0\)\
\-\ complication\\:\\ 0\\.018073605568145197\ \(0\)\
\-\ metabolic\\:\\ 0\\.018039900171099944\ \(0\)\
\-\ denied\\:\\ 0\\.017973450896174147\ \(0\)\
\-\ place\\:\\ 0\\.01794069496108695\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.017908243736787913\ \(0\)\
\-\ night\\:\\ 0\\.01787609160636791\ \(0\)\
\-\ six\\:\\ 0\\.01787609160636791\ \(0\)\
\-\ localized\\:\\ 0\\.01787609160636791\ \(0\)\
\-\ dl\\:\\ 0\\.01781266292341888\ \(0\)\
\-\ completely\\:\\ 0\\.017781375884498914\ \(0\)\
\-\ male\\:\\ 0\\.017720105923520964\ \(0\)\
\-\ orthopedic\\:\\ 0\\.017658960466070253\ \(0\)\
\-\ become\\:\\ 0\\.017658960466070253\ \(0\)\
\-\ painful\\:\\ 0\\.017599326852295274\ \(0\)\
\-\ fevers\\:\\ 0\\.017569888015514443\ \(0\)\
\-\ remainder\\:\\ 0\\.017511745311993374\ \(0\)\
\-\ able\\:\\ 0\\.01745455581059751\ \(0\)\
\-\ period\\:\\ 0\\.01739828876083815\ \(0\)\
\-\ recently\\:\\ 0\\.017370491948778627\ \(0\)\
\-\ reduction\\:\\ 0\\.017370491948778627\ \(0\)\
\-\ improvement\\:\\ 0\\.017370491948778627\ \(0\)\
\-\ 29\\:\\ 0\\.017342914876661602\ \(0\)\
\-\ despite\\:\\ 0\\.017315554097532593\ \(0\)\
\-\ complaint\\:\\ 0\\.01723473624083859\ \(0\)\
\-\ urinary\\:\\ 0\\.017208207736902837\ \(0\)\
\-\ those\\:\\ 0\\.01702795088632403\ \(0\)\
\-\ 65\\:\\ 0\\.01702795088632403\ \(0\)\
\-\ incidentally\\:\\ 0\\.016953460907580504\ \(0\)\
\-\ numerous\\:\\ 0\\.01680908934844327\ \(0\)\
\-\ clinic\\:\\ 0\\.0167622633909309\ \(0\)\
\-\ intervention\\:\\ 0\\.016716057663032757\ \(0\)\
\-\ their\\:\\ 0\\.016515386799478074\ \(0\)\
\-\ open\\:\\ 0\\.016450982235621903\ \(0\)\
\-\ complaints\\:\\ 0\\.01638774519062474\ \(0\)\
\-\ continued\\:\\ 0\\.016305173727312473\ \(0\)\
\-\ room\\:\\ 0\\.01628483266993678\ \(0\)\
\-\ normal\\:\\ 0\\.016249719971999164\ \(0\)\
\-\ near\\:\\ 0\\.016204634161927228\ \(0\)\
\-\ last\\:\\ 0\\.01618486934159938\ \(0\)\
\-\ four\\:\\ 0\\.016126238021023653\ \(0\)\
\-\ characteristic\\:\\ 0\\.016087690872394766\ \(0\)\
\-\ compared\\:\\ 0\\.016087690872394766\ \(0\)\
\-\ features\\:\\ 0\\.01601185133215968\ \(0\)\
\-\ taken\\:\\ 0\\.015901096586836694\ \(0\)\
\-\ references\\:\\ 0\\.01586494619643057\ \(0\)\
\-\ there\\:\\ 0\\.0158359523162854\ \(0\)\
\-\ done\\:\\ 0\\.01582916658579373\ \(0\)\
\-\ from\\:\\ 0\\.015806529129138148\ \(0\)\
\-\ formation\\:\\ 0\\.01577617597515422\ \(0\)\
\-\ initially\\:\\ 0\\.015605137727427398\ \(0\)\
\-\ additional\\:\\ 0\\.01542620202113858\ \(0\)\
\-\ typical\\:\\ 0\\.015378953243014094\ \(0\)\
\-\ complications\\:\\ 0\\.015240929380398751\ \(0\)\
\-\ an\\:\\ 0\\.015219055643578651\ \(0\)\
\-\ history\\:\\ 0\\.015205573585447149\ \(0\)\
\-\ hours\\:\\ 0\\.015166545294515912\ \(0\)\
\-\ pressure\\:\\ 0\\.015151856929842935\ \(0\)\
\-\ extremities\\:\\ 0\\.015122664446048048\ \(0\)\
\-\ causes\\:\\ 0\\.015036524724926005\ \(0\)\
\-\ rare\\:\\ 0\\.015022372650928612\ \(0\)\
\-\ 14\\:\\ 0\\.014856880049738088\ \(0\)\
\-\ active\\:\\ 0\\.014776987669713993\ \(0\)\
\-\ cord\\:\\ 0\\.014750758362266787\ \(0\)\
\-\ course\\:\\ 0\\.014698884076209307\ \(0\)\
\-\ tumors\\:\\ 0\\.01463510750181586\ \(0\)\
\-\ laboratory\\:\\ 0\\.014450488685734677\ \(0\)\
\-\ diagnosed\\:\\ 0\\.014414709075097835\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.014402863625835122\ \(0\)\
\-\ reported\\:\\ 0\\.014332623371231597\ \(0\)\
\-\ ap\\:\\ 0\\.01428657014192175\ \(0\)\
\-\ later\\:\\ 0\\.014241116971777797\ \(0\)\
\-\ peripheral\\:\\ 0\\.014229845616395422\ \(0\)\
\-\ required\\:\\ 0\\.014207411574732548\ \(0\)\
\-\ nerve\\:\\ 0\\.014196248424547407\ \(0\)\
\-\ spinal\\:\\ 0\\.01413000944479339\ \(0\)\
\-\ muscle\\:\\ 0\\.01413000944479339\ \(0\)\
\-\ identified\\:\\ 0\\.014108206364719548\ \(0\)\
\-\ palpable\\:\\ 0\\.01398017432705148\ \(0\)\
\-\ signs\\:\\ 0\\.013907603002087965\ \(0\)\
\-\ weight\\:\\ 0\\.01387695728708855\ \(0\)\
\-\ new\\:\\ 0\\.013766838255927873\ \(0\)\
\-\ does\\:\\ 0\\.013756997681120351\ \(0\)\
\-\ given\\:\\ 0\\.013688880118848846\ \(0\)\
\-\ 30\\:\\ 0\\.013575115207271253\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.013547244368294601\ \(0\)\
\-\ although\\:\\ 0\\.013547244368294601\ \(0\)\
\-\ internal\\:\\ 0\\.013411135500122226\ \(0\)\
\-\ week\\:\\ 0\\.013384539578751657\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.013323259784211432\ \(0\)\
\-\ density\\:\\ 0\\.013195462289956633\ \(0\)\
\-\ joint\\:\\ 0\\.013112792984005217\ \(0\)\
\-\ air\\:\\ 0\\.013016108325594536\ \(0\)\
\-\ area\\:\\ 0\\.012891227645934613\ \(0\)\
\-\ such\\:\\ 0\\.012800416059301118\ \(0\)\
\-\ abscess\\:\\ 0\\.012778077787949049\ \(0\)\
\-\ medical\\:\\ 0\\.012646971197038894\ \(0\)\
\-\ show\\:\\ 0\\.012632703359333579\ \(0\)\
\-\ only\\:\\ 0\\.01243212093602928\ \(0\)\
\-\ brain\\:\\ 0\\.012405337837435953\ \(0\)\
\-\ loss\\:\\ 0\\.01212354584171533\ \(0\)\
\-\ when\\:\\ 0\\.012020490241993819\ \(0\)\
\-\ appearance\\:\\ 0\\.011996677989426332\ \(0\)\
\-\ abnormal\\:\\ 0\\.011955393703382782\ \(0\)\
\-\ following\\:\\ 0\\.011937848914736104\ \(0\)\
\-\ head\\:\\ 0\\.011868539056250247\ \(0\)\
\-\ trauma\\:\\ 0\\.011556909209706409\ \(0\)\
\-\ significant\\:\\ 0\\.011489571916416459\ \(0\)\
\-\ lesions\\:\\ 0\\.011428547361053669\ \(0\)\
\-\ evidence\\:\\ 0\\.011295024330594573\ \(0\)\
\-\ these\\:\\ 0\\.011237282629609296\ \(0\)\
\-\ both\\:\\ 0\\.01109697626088315\ \(0\)\
\-\ more\\:\\ 0\\.010926990974081717\ \(0\)\
\-\ symptoms\\:\\ 0\\.010887916099949806\ \(0\)\
\-\ physical\\:\\ 0\\.010790002322235138\ \(0\)\
\-\ consistent\\:\\ 0\\.010790002322235138\ \(0\)\
\-\ bilateral\\:\\ 0\\.010694761898333712\ \(0\)\
\-\ imaging\\:\\ 0\\.010457896178472469\ \(0\)\
\-\ other\\:\\ 0\\.010334164898138423\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010315794758499926\ \(0\)\
\-\ posterior\\:\\ 0\\.010290238003492718\ \(0\)\
\-\ small\\:\\ 0\\.010264867117439172\ \(0\)\
\-\ exam\\:\\ 0\\.010017452242382917\ \(0\)\
\-\ may\\:\\ 0\\.010014089850357774\ \(0\)\
\-\ but\\:\\ 0\\.00984036723405721\ \(0\)\
\-\ findings\\:\\ 0\\.009821234746669757\ \(0\)\
\-\ multiple\\:\\ 0\\.00973331156810335\ \(0\)\
\-\ surgical\\:\\ 0\\.00967183893856924\ \(0\)\
\-\ within\\:\\ 0\\.009165127167791266\ \(0\)\
\-\ which\\:\\ 0\\.009048531342339435\ \(0\)\
\-\ not\\:\\ 0\\.007855875895484\ \(0\)\
\-\ mass\\:\\ 0\\.007601103568827943\ \(0\)\
\-\ at\\:\\ 0\\.0075163185738889695\ \(0\)\
\-\ this\\:\\ 0\\.006837849761437721\ \(0\)\
\-\ no\\:\\ 0\\.006471112925475474\ \(0\)\
\-\ year\\:\\ 0\\.00613265492039022\ \(0\)\
\-\ old\\:\\ 0\\.0058894715947576965\ \(0\)\
